Literature DB >> 11098884

Commentary: considerations on the pharmacotherapy of attention deficits and hyperactivity in children with autism and other pervasive developmental disorders.

R Nicolson1, F X Castellanos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11098884     DOI： 10.1023/a:1005511809545

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN： 0162-3257


× No keyword cloud information.
  3 in total

1.  Analysis of WISC-III, Stanford-Binet:IV, and academic achievement test scores in children with autism.

Authors:  Susan Dickerson Mayes; Susan L Calhoun
Journal:  J Autism Dev Disord       Date:  2003-06

2.  Effects of extended release methylphenidate treatment on ratings of attention-deficit/hyperactivity disorder (ADHD) and associated behavior in children with autism spectrum disorders and ADHD symptoms.

Authors:  Deborah A Pearson; Cynthia W Santos; Michael G Aman; L Eugene Arnold; Charles D Casat; Rosleen Mansour; David M Lane; Katherine A Loveland; Oscar G Bukstein; Susan W Jerger; Perry Factor; Salome Vanwoerden; Evelyn Perez; Lynne A Cleveland
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-06       Impact factor: 2.576

3.  Biases in Understanding Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder in Japan.

Authors:  Mami Miyasaka; Shogo Kajimura; Michio Nomura
Journal:  Front Psychol       Date:  2018-02-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.